NasdaqGS - Nasdaq Real Time Price USD

2seventy bio, Inc. (TSVT)

Compare

4.9800

+0.0100

+(0.20%)

At close: April 17 at 4:00:00 PM EDT

4.9700

-0.01

(-0.20%)

After hours: April 17 at 5:39:02 PM EDT

High Growth Tech Stocks In The US For April 2025

In the midst of significant market volatility, with the Dow Jones dropping 1,800 points and the Nasdaq sliding by 6% due to a tech sell-off led by chipmakers and Tesla, investors are closely monitoring high-growth tech stocks in the United States. In such turbulent times, identifying strong stocks often involves looking for companies that demonstrate resilience through innovation and adaptability to shifting economic conditions.

Simply Wall St. 9 days ago

WAY

TSVT
+0.20%
TENB
April 2025's Promising Penny Stock Highlights

As the U.S. market navigates a period of volatility with investors closely monitoring new tariffs and economic indicators, opportunities for growth can still be found in less conventional areas. Penny stocks, despite their somewhat outdated moniker, remain a relevant investment area for those interested in smaller or newer companies that might offer surprising value. By focusing on penny stocks with strong financial foundations, investors may discover potential long-term opportunities that...

Simply Wall St. 18 days ago

TSVT
+0.20%
EQC
2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results

CAMBRIDGE, Mass., March 25, 2025--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024.

Business Wire 25 days ago

TSVT
+0.20%
Exploring High Growth Tech Stocks In The US March 2025

Over the last 7 days, the United States market has experienced a 3.7% decline, although it has shown a 6.9% increase over the past year with earnings projected to grow by 14% annually. In this context of fluctuating yet promising growth, identifying high-growth tech stocks involves evaluating their potential for innovation and scalability in alignment with broader market trends.

Simply Wall St. last month

VTEX

GYRE

TSVT
+0.20%
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

CAMBRIDGE, Mass., March 11, 2025--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) ("BMS") will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash transaction for a total equity value of approximately $286 million, or $102 million net of estimated cash. The deal represents an 88% premium to the closing price of $2.66 on March 7, 2025.

Business Wire last month

TSVT
+0.20%
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference

CAMBRIDGE, Mass., February 25, 2025--2seventy bio, Inc. (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming TD Cowen 45th Annual Healthcare Conference on March 5, 2025 at 11:10 a.m. ET in Boston, Mass.

Business Wire last month

TSVT
+0.20%
3 US Penny Stocks With Market Caps Under $200M

The U.S. stock market has been experiencing fluctuations, with the S&P 500 recently reaching record highs while futures indicate a slightly lower open. Penny stocks, though an older term, still capture interest due to their potential for growth at accessible price points. These stocks often represent smaller or newer companies and can offer intriguing opportunities when backed by strong financials and fundamentals.

Simply Wall St. last month

PETS

KYTX

TSVT
+0.20%
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results

CAMBRIDGE, Mass., February 06, 2025--2seventy bio, Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS).

Business Wire 2 months ago

TSVT
+0.20%
US Penny Stocks Spotlight: uCloudlink Group Among 3 Noteworthy Picks

As the U.S. stock market experiences a surge, with major indices like the S&P 500 and Dow Jones Industrial Average posting their best weekly gains in months, investors are looking for opportunities beyond traditional large-cap stocks. Penny stocks, often associated with smaller or newer companies, continue to intrigue investors due to their potential for significant growth when supported by solid financial health. Despite being a somewhat outdated term, penny stocks remain relevant as they...

Simply Wall St. 2 months ago

MPU

UCL

TSVT
+0.20%
US Penny Stocks To Watch In December 2024

As U.S. markets experience a mixed performance with the S&P 500 and Nasdaq Composite recently hitting record highs but facing resistance, investors are keenly watching for opportunities that might offer substantial returns. Though the term 'penny stock' might sound like a relic of past trading days, the opportunity it points to is still relevant. For those looking to invest in smaller or newer companies, penny stocks can offer surprising value when built on solid financial foundations,...

Simply Wall St. 4 months ago

TSVT
+0.20%
HUIZ

VFF
US$8.25: That's What Analysts Think 2seventy bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results

Shareholders in 2seventy bio, Inc. ( NASDAQ:TSVT ) had a terrible week, as shares crashed 22% to US$3.92 in the week...

Simply Wall St. 5 months ago

TSVT
+0.20%
2seventy bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

2seventy bio ( NASDAQ:TSVT ) Third Quarter 2024 Results Key Financial Results Revenue: US$13.5m (up 13% from 3Q 2023...

Simply Wall St. 5 months ago

TSVT
+0.20%
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

CAMBRIDGE, Mass., November 12, 2024--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the third quarter ended September 30, 2024.

Business Wire 5 months ago

TSVT
+0.20%
3 Promising US Penny Stocks With At Least $100M Market Cap

As U.S. stock markets reach record highs following the recent presidential election, investors are keenly exploring diverse opportunities across various sectors. Penny stocks, though often overlooked, represent a niche where smaller or newer companies can offer significant growth potential at lower price points. While the term may seem outdated, these stocks can still be compelling investments when backed by strong financial health and solid fundamentals.

Simply Wall St. 5 months ago

OB

HBIO

TSVT
+0.20%
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference

CAMBRIDGE, Mass., November 04, 2024--2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held at 8:00 a.m. ET.

Business Wire 5 months ago

TSVT
+0.20%
High Growth Tech Stocks To Watch In October 2024

Over the last 7 days, the United States market has dropped by 1.0%, yet it has seen a substantial rise of 38% over the past year, with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability to capitalize on these promising earnings projections.

Simply Wall St. 5 months ago

PGEN

HEAR

TSVT
+0.20%
2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance

CAMBRIDGE, Mass., September 25, 2024--2seventy bio, Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will discontinue enrollment in its ongoing Phase 3 KarMMa-9 study evaluating Abecma® (idecabtagene vicleucel; ide-cel) with lenalidomide maintenance versus lenalidomide maintenance alone in patients with newly diagnosed multiple myeloma (NDMM) who have suboptimal response to autologous stem cell transplant.

Business Wire 6 months ago

TSVT
+0.20%
2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass., August 29, 2024--2seventy bio, Inc. (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference on September 6, 2024 at 12:20 p.m. ET in New York.

Business Wire 7 months ago

TSVT
+0.20%
2seventy bio, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Last week saw the newest quarterly earnings release from 2seventy bio, Inc. ( NASDAQ:TSVT ), an important milestone in...

Simply Wall St. 8 months ago

TSVT
+0.20%
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress

CAMBRIDGE, Mass., August 07, 2024--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the second quarter ended June 30, 2024.

Business Wire 8 months ago

TSVT
+0.20%

Performance Overview

Return	TSVT	S&P 500 (^GSPC)
YTD	+69.39%	-10.18%
1-Year	-1.58%	+5.19%
3-Year	-70.41%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

2seventy bio, Inc. (TSVT)

High Growth Tech Stocks In The US For April 2025

April 2025's Promising Penny Stock Highlights

2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results

Exploring High Growth Tech Stocks In The US March 2025

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference

3 US Penny Stocks With Market Caps Under $200M

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results

US Penny Stocks Spotlight: uCloudlink Group Among 3 Noteworthy Picks

US Penny Stocks To Watch In December 2024

US$8.25: That's What Analysts Think 2seventy bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest Results

2seventy bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

3 Promising US Penny Stocks With At Least $100M Market Cap

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference

High Growth Tech Stocks To Watch In October 2024

2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance

2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare Conference

2seventy bio, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress

Performance Overview